Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Anticipated to Grow Globally at a CAGR of 23.6% during 2021-26

Dublin, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Research Report: Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering. The "Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market" is likely to grow at a CAGR of around 23.6% during the forecast period, i.e., 2021-26, says the author. The market growth primarily attributes to the rising demand for reducing the cost of novel drug discovery and their production. Additionally, the adoption of artificial intelligence is significantly increasing, as faster, efficient, and cost-effective drug discovery is gaining momentum amongst the pharmaceutical industry stakeholders. The research report, states that the burgeoning volume of data generated by the molecule screening processes & preclinical studies is another crucial factor fueling the adoption of artificial intelligence, thereby propelling market growth.